X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (320) 320
Conference Proceeding (117) 117
Book Review (20) 20
Publication (18) 18
Book / eBook (3) 3
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (225) 225
index medicus (127) 127
humans (124) 124
male (80) 80
female (76) 76
adult (75) 75
chemical sciences (68) 68
organic chemistry (66) 66
gastroenterology and hepatology (63) 63
middle aged (54) 54
inflammatory bowel disease (51) 51
inflammatory-bowel-disease (47) 47
crohn's disease (46) 46
crohns-disease (42) 42
ulcerative-colitis (38) 38
life sciences (36) 36
young adult (32) 32
inflammatory bowel diseases (30) 30
risk factors (30) 30
ulcerative colitis (30) 30
adolescent (25) 25
treatment outcome (25) 25
aged (24) 24
infliximab (24) 24
abridged index medicus (23) 23
inflammatory bowel diseases - drug therapy (23) 23
surgery (23) 23
pharmacology & pharmacy (22) 22
therapy (22) 22
crohn disease - drug therapy (20) 20
probiotics (19) 19
colitis, ulcerative - drug therapy (18) 18
immunosuppressive agents - therapeutic use (18) 18
microbiota (18) 18
prospective studies (18) 18
retrospective studies (18) 18
case-control studies (17) 17
health aspects (17) 17
intestine (17) 17
bacteria (16) 16
gastrointestinal diseases (15) 15
inflammatory bowel diseases - microbiology (15) 15
medical research (15) 15
medicine, experimental (15) 15
metaanalysis (15) 15
patients (15) 15
risk (15) 15
colitis (14) 14
crohn disease - microbiology (14) 14
double-blind (14) 14
escherichia-coli (14) 14
feces - microbiology (14) 14
follow-up studies (14) 14
microbiology and parasitology (14) 14
multivariate analysis (14) 14
recurrence (14) 14
16s ribosomal-rna (13) 13
crohns disease (13) 13
human health and pathology (13) 13
immunology (13) 13
inflammatory bowel diseases - complications (13) 13
management (13) 13
prevalence (13) 13
research (13) 13
azathioprine (12) 12
bacteriology (12) 12
care and treatment (12) 12
crohn disease - complications (12) 12
diagnosis (12) 12
fecal microbiota (12) 12
inflammation (12) 12
intestinal mucosa - microbiology (12) 12
probiotics - therapeutic use (12) 12
time factors (12) 12
analysis (11) 11
cohort studies (11) 11
crohn disease - pathology (11) 11
hépatology and gastroenterology (11) 11
ibd (11) 11
placebo-controlled trial (11) 11
severity of illness index (11) 11
animals (10) 10
anti-inflammatory agents, non-steroidal - therapeutic use (10) 10
biochemistry, molecular biology (10) 10
dysbiosis (10) 10
epidemiology (10) 10
intestines - microbiology (10) 10
microbiology (10) 10
molecular biology (10) 10
population-based cohort (10) 10
biopsy (9) 9
classification (9) 9
colitis, ulcerative - pathology (9) 9
dysplasia (9) 9
gastroenterology (9) 9
gradient gel-electrophoresis (9) 9
maintenance therapy (9) 9
saccharomyces-boulardii (9) 9
tumor necrosis factor-alpha - antagonists & inhibitors (9) 9
antibiotics (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 03/2016, Volume 65, Issue 3, pp. 415 - 425
Background Crohn's disease (CD)-associated dysbiosis is characterised by a loss of Faecalibacterium prausnitzii, whose culture supernatant exerts an... 
EPITHELIAL BARRIER | INFLAMMATORY-BOWEL-DISEASE | IMMUNE-SYSTEM | COLITIS | CAMPYLOBACTER-CONCISUS | FECAL MICROBIOTA | GUT | REGULATORY T-CELLS | GASTROENTEROLOGY & HEPATOLOGY | TIGHT JUNCTION | SEGMENTED FILAMENTOUS BACTERIA | Intestinal Mucosa - metabolism | Humans | Bacterial Proteins - chemistry | Crohn Disease - metabolism | Molecular Sequence Data | Male | NF-kappa B - metabolism | Dysbiosis - microbiology | Bacterial Proteins - therapeutic use | Colitis - chemically induced | Anti-Inflammatory Agents - therapeutic use | Crohn Disease - microbiology | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Biomarkers - metabolism | Amino Acid Sequence | Cell Line | Intestinal Mucosa - microbiology | Clostridiales - metabolism | Dysbiosis - metabolism | Animals | Crohn Disease - pathology | Colitis - metabolism | Bacterial Proteins - metabolism | Mice | Mice, Inbred BALB C | Dysbiosis - pathology | Bacterial Proteins - isolation & purification | Colitis - prevention & control | Intestinal Mucosa - pathology | Proteins | Inflammatory bowel disease | Probiotics | Immunology | Metabolites | E coli | Work stations | Homeostasis | Bacteria | Scientific imaging | Mass spectrometry | Crohns disease | Index Medicus | Abridged Index Medicus | Chemical Sciences | microbiota | Faecalibacterium prausnitzii | dysbiosis | Crohn’s disease | anti-inflammatory protein
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 7, pp. 2084 - 2089
Journal Article
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 10/2008, Volume 105, Issue 43, pp. 16731 - 16736
Journal Article
Journal Article
Gut, ISSN 0017-5749, 2014, Volume 63, Issue 10, pp. 1566 - 1577
Journal Article
Gut, ISSN 0017-5749, 02/2003, Volume 52, Issue 2, pp. 237 - 242
Journal Article
by Walker, Gareth J and Harrison, James W and Heap, Graham A and Voskuil, Michiel D and Andersen, Vibeke and Anderson, Carl A and Ananthakrishnan, Ashwin N and Barrett, Jeffrey C and Beaugerie, Laurent and Bewshea, Claire M and Cole, Andy T and Cummings, Fraser R and Daly, Mark J and Ellul, Pierre and Fedorak, Richard N and Festen, Eleonora A. M and Florin, Timothy H and Gaya, Daniel R and Halfvarson, Jonas and Hart, Ailsa L and Heerasing, Neel M and Hendy, Peter and Irving, Peter and Jones, Samuel E and Koskela, Jukka and Lindsay, James O and Mansfield, John C and McGovern, Dermot and Parkes, Miles and Pollok, Richard C. G and Ramakrishnan, Subramaniam and Rampton, David S and Rivas, Manuel A and Russell, Richard K and Schultz, Michael and Sebastian, Shaji and Seksik, Philippe and Singh, Abhey and So, Kenji and Sokol, Harry and Subramaniam, Kavitha and Todd, Anthony and Annese, Vito and Weersma, Rinse K and Xavier, Ramnik and Ward, Rebecca and Weedon, Michael N and Goodhand, James R and Kennedy, Nicholas A and Ahmad, Tariq and Holden, Arthur L and Andrews, Jane and Auth, Marcus and Babu, Sathish and Bampton, Peter and Banim, Paul and Barnes, Theresa and Basude, Dharam and Beckly, John and Bell, Andy and Bell, Sally and Bhandari, Pradeep and Bloom, Stuart and Border, Dave and Bredin, Francesca and Brookes, Matthew J and Brown, Matthew and Calvert, Chris and Campbell, David and Chanchlani, Neil and Chaudhary, Basant and Chaudhary, Rakesh and Chung-Faye, Guy and Colleypriest, Ben and Connor, Susan and Cooney, Rachel and Cooper, Sheldon and Creed, Tom J and Croft, Nick and Cullen, Sue and D'Amato, Mauro and D'Inca, Renata and Dalal, Helen and Daneshmend, Tawfique K and Das, Debasish and Delaney, Michael and DeSilva, Shanika and Dhar, Anjan and Dharmasiri, Suranga and Direkze, Natalie and Dunckley, Paul and Elphick, David and Everett, Simon M and Feeney, Mark and Fell, John and Foley, Stephen and Franke, Andre and Gavin, Daniel and Gee, Ian and Ghosh, Deb and ... and IBD Pharmacogenetics Study Grp and IBD Pharmacogenetics Study Group and for the IBD Pharmacogenetics Study Group
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 02/2019, Volume 321, Issue 8, pp. 753 - 761
IMPORTANCE Use of thiopurines may be limited by myelosuppression. TPMT pharmacogenetic testing identifies only 25% of at-risk patients of European ancestry.... 
MEDICINE, GENERAL & INTERNAL | S-METHYLTRANSFERASE | POLYMORPHISMS | MANAGEMENT | PREDICTOR | THERAPY | ACUTE LYMPHOBLASTIC-LEUKEMIA | SUSCEPTIBILITY | AZATHIOPRINE | MERCAPTOPURINE INTOLERANCE | CHILDREN | Haplotypes | Crohn Disease - genetics | Genome-Wide Association Study | Colitis, Ulcerative - metabolism | Humans | Methyltransferases - metabolism | Colitis, Ulcerative - genetics | Methyltransferases - genetics | Pyrophosphatases - genetics | Crohn Disease - metabolism | European Continental Ancestry Group | Male | Case-Control Studies | Methyltransferases - therapeutic use | Exome | Young Adult | Crohn Disease - drug therapy | Adolescent | Adult | Female | Leukocyte Count | Polymorphism, Single Nucleotide | Colitis, Ulcerative - drug therapy | Sequence Analysis, DNA - methods | Antimitotic agents | Complications and side effects | Inflammatory bowel diseases | Genetic variation | Myelosuppression | Dosage and administration | Genetic aspects | Research | Antineoplastic agents | Drug therapy | Health aspects | Chromosome 6 | Risk | Genomes | Chromosome deletion | Pharmacology | Gene deletion | Disease control | Patients | Inflammatory bowel disease | White blood cells | Genetic variance | Genotyping | Clonal deletion | Intestine | Deletion | Chromosome 13 | Genetic testing | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
by Frange, Pierre and Assoumou, Pierre and Descamps, Diane and Chéret, Antoine and Goujard, Cécile and Tran, Laurent and Gousset, Marine and Avettand-Fenoël, Véronique and Bocket, Laurence and Tran, Samira and Guinard, Jérôme and Morand-Joubert, Pierre and Nicot, Florence and Plantier, Jean-Christophe and Rogez, Sylvie and Wirden, Pierre and Rouzioux, Christine and Meyer, Laurence and Chaix, Marie-Laure and Abel, S and Abraham, B and Antoniotti, A and Armero, R and Audhuy, B and Aumaitre, H and Beaucaire, G and Beck-Wirth, G and Berger, J.L and Bernard, L and Beuscart, C and Bodard, L and Bouchaud, O and Boue, F and Cabane, J.-P and Cabié, A and Champagne, H and Cheneau, C and Chennebault, J.-M and Cheret, A and Christian, B and Compagnucci, A and Daneluzzi, V and Debab, Y and Dellamonica, P and Delfraissy, F and Devidas, A and Diab, G and Doll, J and Drobacheff-Thebaut, C and Durel, A and Esnault, L and Faba, L and Froguel, E and Garipuy, D and Garrait, V and Geffray, L and Genet, C and Genet, P and Gérard, L and Ghosn, J and Girard, J and Girard, P and Godin-Collet, C and Hochedez, P and Hoen, B and Houlbert, D and Jacomet, C and Jeantils, V and Jidar, K and Klement, E and Lafeuillade, A and Launay, V and Leprêtre, A and Levy, Y and Makhloufi, D and Malbec, D and Martha, B and May, T and Merrien, D and Miailhes, P and Miodovski, C and Morlat, P and Mortier, E and Neau, D and Obadia, M and Patey, O and Pellegrin, L and Perronne, V and Philibert, P and Pialoux, G and Pichancourt, G and Piroth, L and Poinsignon, Y and Poizot-Martin, I and Prazuck, T and Prendki, V and du Clary, F and Quinsat, D and Regnier, A and Reynes, J and ...
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2015, Volume 70, Issue 7, pp. 2084 - 2089
Journal Article
PLoS Genetics, ISSN 1553-7390, 05/2018, Volume 14, Issue 5, pp. e1007329 - e1007329
Journal Article